Search

Showing "11155" results for ""

HIV detectable in CSF of 10% of patients taking successful antiretroviral treatment

Smoking and its consequences: studies probe quitting, relapse and lung disease

AZT not linked to worsening anaemia in patients starting ART in Uganda

No evidence that patients taking long-term efavirenz want to switch to etravirine

Kidney transplant 'feasible' for patients with HIV

Nucleoside/nucleotide analogue therapy slows liver disease in HIV/HBV-co-infected patients

Introducing the new Funding Development Officer

High prevalence and incidence of pre-cancerous cervical lesions in HIV-positive South African women

UNAIDS reports real evidence of progress in global response to HIV

Anti-HIV drugs prevent HIV infection, trial shows – if you take them

It's "much more than merely a directory..."

PrEP, the big issues: iPrEx study directors discuss unanswered questions

Claims that phylogenetic analysis can prove direction of transmission are unfounded, say experts

UK HIV diagnoses fall - because fewer people infected abroad

Bridging the divide: HIV and health systems

Focus on six risk factors could prevent up to 80% of HIV infections in South African women

Depression associated with HIV risk factors for young people in South Africa

Merck halts study of once-daily raltegravir

Receive the latest HIV research and conference news

Showing "11155" results for ""

HIV detectable in CSF of 10% of patients taking successful antiretroviral treatment

Smoking and its consequences: studies probe quitting, relapse and lung disease

AZT not linked to worsening anaemia in patients starting ART in Uganda

No evidence that patients taking long-term efavirenz want to switch to etravirine

Kidney transplant 'feasible' for patients with HIV

Nucleoside/nucleotide analogue therapy slows liver disease in HIV/HBV-co-infected patients

Introducing the new Funding Development Officer

High prevalence and incidence of pre-cancerous cervical lesions in HIV-positive South African women

UNAIDS reports real evidence of progress in global response to HIV

Anti-HIV drugs prevent HIV infection, trial shows – if you take them

It's "much more than merely a directory..."

PrEP, the big issues: iPrEx study directors discuss unanswered questions

Claims that phylogenetic analysis can prove direction of transmission are unfounded, say experts

UK HIV diagnoses fall - because fewer people infected abroad

Bridging the divide: HIV and health systems

Focus on six risk factors could prevent up to 80% of HIV infections in South African women

Depression associated with HIV risk factors for young people in South Africa

Merck halts study of once-daily raltegravir

Receive the latest HIV research and conference news